A carregar...
ETOILE: Real-World Evidence of 24 Months of Ranibizumab 0.5 mg in Patients with Visual Impairment Due to Diabetic Macular Edema
PURPOSE: To evaluate the real-world effectiveness of intravitreal ranibizumab 0.5 mg (Lucentis) in improving visual acuity (VA) in adults with decreased VA due to diabetic macular edema (DME). PATIENTS AND METHODS: Real-world prospective observational 24-month study. Ranibizumab-naïve patients (n=11...
Na minha lista:
| Publicado no: | Clin Ophthalmol |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8185131/ https://ncbi.nlm.nih.gov/pubmed/34113074 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S313081 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|